Q&A: How UW researchers are using AI to speed up drug discovery and development
The University of Washington launched the Institute for Innovations in Drug Delivery and Disposition in July 2026 to address challenges in drug development by combining AI with expertise in pharmacology and biotechnology. Researchers aim to improve the efficiency of turning promising molecules into viable drugs by focusing on overlooked aspects like delivery methods and molecular stability. The institute uses AI to accelerate the identification of molecules that can effectively reach their targets and function within the body. This approach is expected to reduce the high failure rate of drug candidates and speed up the development of new treatments.
University of Washington researchers are using AI to improve how drugs are designed and delivered, focusing on challenges that often cause drug candidates to fail.
This work could lead to faster development of safer, more effective drugs by addressing issues like how molecules interact with the body and reach their targets.
The story highlights collaboration between science and technology to solve real-world health problems, offering hope for more efficient medical innovations.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.